American Cryostem (American Cryostem) Pre-Tax Income : $-3.81 Mil (TTM As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. American Cryostem's pretax income for the three months ended in Jun. 2022 was $-0.40 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2022 was $-3.81 Mil. American Cryostem's pretax margin was -934.88%.

American Cryostem Pre-Tax Income Historical Data

The historical data trend for American Cryostem's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Pre-Tax Income Chart

American Cryostem Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Pre-Tax Income

Get a 7-Day Free Trial

-1.22

-1.49

-1.08

-1.18

-2.88

American Cryostem Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Pre-Tax Income	Get a 7-Day Free Trial															-0.47	-2.06	-0.38	-0.96	-0.40

Competitive Comparison of American Cryostem's Pre-Tax Income

For the Biotechnology subindustry, American Cryostem's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Cryostem's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where American Cryostem's Pre-Tax Income falls into.

American Cryostem Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

American Cryostem's Pretax Income for the fiscal year that ended in Sep. 2021 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.205	+	-0.57	+	-0.104	+	0	+	-0.00099999999999989
	=	-2.88

American Cryostem's Pretax Income for the quarter that ended in Jun. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.311	+	-0.066	+	-0.025	+	0	+	0
	=	-0.40

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.81 Mil.

American Cryostem (OTCPK:CRYO) Pre-Tax Income Explanation

American Cryostem's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.402	/	0.043
	=	-934.88%

American Cryostem Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of American Cryostem's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cryostem (American Cryostem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724

Website

http://www.americancryostem.com

American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.

Executives

John S Arnone	director, officer: Chairman	111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski	director, officer: COO	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc.	10 percent owner	188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill	10 percent owner	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina	director, 10 percent owner, officer: President and Director	1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915